| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Agomelatine reduces brain, kidney and liver oxidative stress but increases plasma cytokine production in the rats with chronic mild stress-induced depression
|
Demirdaş, Arif
|
|
2016
|
31 |
6 |
p. 1445-1453
|
artikel
|
| 2 |
Altered expression and localization of synaptophysin in developing cerebellar cortex of neonatal rats due to maternal diabetes mellitus
|
Hami, Javad
|
|
2016
|
31 |
6 |
p. 1369-1380
|
artikel
|
| 3 |
Altered urinary porphyrins and mercury exposure as biomarkers for autism severity in Egyptian children with autism spectrum disorder
|
Khaled, Eman M.
|
|
2016
|
31 |
6 |
p. 1419-1426
|
artikel
|
| 4 |
Brain edema: a valid endpoint for measuring hepatic encephalopathy?
|
Bémeur, Chantal
|
|
2016
|
31 |
6 |
p. 1249-1258
|
artikel
|
| 5 |
Clinical science workshop: targeting the gut-liver-brain axis
|
Patel, Vishal C.
|
|
2015
|
31 |
6 |
p. 1327-1337
|
artikel
|
| 6 |
Current state of knowledge of hepatic encephalopathy (part II): changes in brain white matter tracts integrity are associated with cognitive deficits in minimal hepatic encephalopathy
|
Montoliu, Carmina
|
|
2016
|
31 |
6 |
p. 1359-1360
|
artikel
|
| 7 |
Current state of knowledge of hepatic encephalopathy (part III): non-absorbable disaccharides
|
Morgan, Marsha Y.
|
|
2016
|
31 |
6 |
p. 1361-1364
|
artikel
|
| 8 |
Current state of knowledge of hepatic encephalopathy (part I): newer treatment strategies for hyperammonemia in liver failure
|
Kristiansen, Rune Gangsoy
|
|
2016
|
31 |
6 |
p. 1357-1358
|
artikel
|
| 9 |
Current state of knowledge of hepatic encephalopathy (Part V): clinical efficacy of L-ornithine-L-aspartate in the management of HE
|
Kircheis, Gerald
|
|
2016
|
31 |
6 |
p. 1365-1367
|
artikel
|
| 10 |
Delayed bradykinin postconditioning modulates intrinsic neuroprotective enzyme expression in the rat CA1 region after cerebral ischemia: a proteomic study
|
Nemethova, Miroslava
|
|
2016
|
31 |
6 |
p. 1391-1403
|
artikel
|
| 11 |
Diagnosis of minimal hepatic encephalopathy in a tertiary care center from eastern Romania: validation of the psychometric hepatic encephalopathy score (PHES)
|
Badea, Mircea Alexandru
|
|
2016
|
31 |
6 |
p. 1463-1471
|
artikel
|
| 12 |
Evidence of oxidative stress in brain and liver of young rats submitted to experimental galactosemia
|
Castro, Márcia B.
|
|
2016
|
31 |
6 |
p. 1381-1390
|
artikel
|
| 13 |
Gene expression profiling of brain cortex microvessels may support brain vasodilation in acute liver failure rat models
|
Palenzuela, Lluis
|
|
2016
|
31 |
6 |
p. 1405-1417
|
artikel
|
| 14 |
Glycine and hyperammonemia: potential target for the treatment of hepatic encephalopathy
|
Kristiansen, Rune Gangsøy
|
|
2016
|
31 |
6 |
p. 1269-1273
|
artikel
|
| 15 |
1H and 31P magnetic resonance spectroscopy in a rat model of chronic hepatic encephalopathy: in vivo longitudinal measurements of brain energy metabolism
|
Rackayova, Veronika
|
|
2015
|
31 |
6 |
p. 1303-1314
|
artikel
|
| 16 |
Hepatic encephalopathy: present and future
|
Davies, Nathan
|
|
2016
|
31 |
6 |
p. 1209-1210
|
artikel
|
| 17 |
Introduction: current state of knowledge of hepatic encephalopathy
|
Mullen, Kevin D.
|
|
2016
|
31 |
6 |
p. 1355
|
artikel
|
| 18 |
Neuroinflammation in liver disease: sessional talks from ISHEN
|
Wright, Gavin
|
|
2016
|
31 |
6 |
p. 1339-1354
|
artikel
|
| 19 |
New technologies – new insights into the pathogenesis of hepatic encephalopathy
|
Baker, Luisa
|
|
2016
|
31 |
6 |
p. 1259-1267
|
artikel
|
| 20 |
No effect of albumin infusion on the prevention of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt
|
Riggio, Oliviero
|
|
2015
|
31 |
6 |
p. 1275-1281
|
artikel
|
| 21 |
Pathogenesis of hepatic encephalopathy in cirrhosis: the concept of synergism revisited
|
Butterworth, Roger F.
|
|
2015
|
31 |
6 |
p. 1211-1215
|
artikel
|
| 22 |
Probiotics in management of hepatic encephalopathy
|
Sharma, Barjesh Chander
|
|
2016
|
31 |
6 |
p. 1295-1301
|
artikel
|
| 23 |
Pyridoxine-dependent epilepsy: report on three families with neuropathology
|
Marguet, Florent
|
|
2016
|
31 |
6 |
p. 1435-1443
|
artikel
|
| 24 |
Qualifying and quantifying minimal hepatic encephalopathy
|
Morgan, Marsha Y.
|
|
2015
|
31 |
6 |
p. 1217-1229
|
artikel
|
| 25 |
Quantitative magnetic resonance imaging in patients with cirrhosis: a cross-sectional study
|
Grover, Vijay P. B.
|
|
2015
|
31 |
6 |
p. 1315-1325
|
artikel
|
| 26 |
Subchronic treatment with acai frozen pulp prevents the brain oxidative damage in rats with acute liver failure
|
Souza Machado, Fernanda de
|
|
2016
|
31 |
6 |
p. 1427-1434
|
artikel
|
| 27 |
The concept of “the inflamed brain” in acute liver failure: mechanisms and new therapeutic opportunities
|
Butterworth, Roger F.
|
|
2015
|
31 |
6 |
p. 1283-1287
|
artikel
|
| 28 |
Timosaponin B-II ameliorates scopolamine-induced cognition deficits by attenuating acetylcholinesterase activity and brain oxidative damage in mice
|
Zhao, Xu
|
|
2016
|
31 |
6 |
p. 1455-1461
|
artikel
|
| 29 |
What is new about diet in hepatic encephalopathy
|
Merli, Manuela
|
|
2015
|
31 |
6 |
p. 1289-1294
|
artikel
|
| 30 |
What we know: the inflammatory basis of hepatic encephalopathy
|
Milewski, K.
|
|
2015
|
31 |
6 |
p. 1239-1247
|
artikel
|
| 31 |
Where are we going? Translational research in hepatic encephalopathy
|
Amodio, Piero
|
|
2015
|
31 |
6 |
p. 1231-1237
|
artikel
|
Tijdschrift beschrijving